Growth vs. Value Debate

The discussion delves into the stark contrast between beaten-up cyclicals and struggling growth stocks, highlighting the challenges growth names face due to inflated past performance. With significant year-over-year growth figures, companies like Teladoc still see their stocks plummet, raising questions about whether the growth narrative has become overly optimistic. There's a suggestion that 2021 might favor value investors as growth stocks grapple with tough comparisons and expectations.